| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,811 |
10,885 |
$793K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,859 |
5,428 |
$617K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,997 |
2,980 |
$273K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,212 |
2,209 |
$207K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,689 |
2,650 |
$198K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,344 |
1,337 |
$121K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,563 |
3,550 |
$82K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,798 |
6,677 |
$75K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,318 |
2,277 |
$41K |
| 92551 |
|
2,547 |
2,534 |
$19K |
| D0190 |
|
943 |
941 |
$16K |
| 96127 |
|
3,129 |
3,048 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
858 |
844 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
235 |
230 |
$8K |
| 83655 |
|
382 |
375 |
$7K |
| 99188 |
|
943 |
942 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
329 |
243 |
$6K |
| 96160 |
|
2,601 |
2,581 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
120 |
116 |
$4K |
| 36416 |
|
279 |
270 |
$3K |
| 97802 |
|
700 |
696 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
185 |
184 |
$2K |
| 99000 |
|
399 |
396 |
$2K |
| 0071A |
|
34 |
30 |
$1K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,884 |
1,879 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
45 |
45 |
$924.70 |
| 96161 |
|
377 |
371 |
$610.44 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
40 |
$454.38 |
| 69210 |
|
13 |
13 |
$429.66 |
| 87631 |
|
89 |
89 |
$375.69 |
| 85018 |
|
303 |
297 |
$354.78 |
| 92567 |
|
14 |
14 |
$120.11 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
63 |
61 |
$0.32 |
| 99173 |
|
1,541 |
1,534 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
254 |
248 |
$0.00 |
| 98960 |
|
2,103 |
2,092 |
$0.00 |
| 90686 |
|
76 |
75 |
$0.00 |
| 90647 |
|
12 |
12 |
$0.00 |
| 91307 |
|
26 |
24 |
$0.00 |